Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Reza M. Haque"'
Publikováno v:
American Journal of Ophthalmology. 194:7-15
Purpose To evaluate the efficacy/safety of an ophthalmic suspension of povidone-iodine (PVP-I) 0.6% and dexamethasone 0.1% in patients with acute adenoviral conjunctivitis. Design Multicenter, randomized, vehicle-controlled, double-masked trial. Meth
Autor:
Kelly K. Nichols, Michael D. Schiewe, Richard C. Zink, Katherine M. Bickle, Reza M. Haque, Jason J. Nichols
Publikováno v:
Eye & Contact Lens: Science & Clinical Practice. 38:73-79
The purpose of this pilot study was to evaluate the safety and efficacy of azithromycin ophthalmic solution 1% in patients with contact lens-related dry eye (CLDE).This was a 4-week, single-center, open-label clinical trial in patients diagnosed with
Autor:
Reza M. Haque, R. Kim Brazzell, Paul L. Kaufman, Robert Ritch, Carol A. Rasmussen, Jason L Vittitow
Publikováno v:
Translational vision sciencetechnology. 3(5)
To evaluate the safety, tolerability, and intraocular pressure (IOP)-lowering effect of Latrunculin-B (Lat-B), a marine macrolide that disrupts the actin cytoskeleton, in patients with ocular hypertension (OHT) or early primary open-angle glaucoma (P
Autor:
Gail Torkildsen, Richard C. Zink, Regis P. Kowalski, Stephen C. Pflugfelder, Reza M. Haque, Kurt E. Brubaker, Francis S. Mah
Publikováno v:
Cornea. 29(8)
PURPOSE To evaluate the effect of 4 weeks of treatment with azithromycin ophthalmic solution 1% on eyelid bacterial load, tear cytokines, and signs and symptoms of blepharitis. METHODS Twenty-six subjects (mean age 64.2 years; 65% female; 100% white)
Autor:
William C. Stewart, Christopher S. Crean, Kurt E. Brubaker, Richard C. Zink, David G. Hwang, Reza M. Haque
Publikováno v:
American journal of ophthalmology. 150(5)
Purpose To evaluate the ocular pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor in subjects undergoing cataract surgery. Design Multicenter, open-label, randomized study. Methods Subjects scheduled for routine
Publikováno v:
Drug safety. 25(8)
This review summarises the safety of unoprostone isopropyl (both at the 0.12 and 0.15% concentrations) instilled twice daily in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH). For unoprostone 0.15%, combined data from tw